re: sues gsk article.. smh today
could simply be a ploy to get back the IP rights for Relenza. It is unlikely Glaxo will cough up hard cash, they could hold it up in the courts for years before BTA gets a penny....
BTA Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held